Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OLOPATADINE HYDROCHLORIDE USP, with a corresponding US DMF Number 31761.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 13, 2024, and payment made on August 07, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II